GlassScriptPhysician profile
Locke W Barber
NPI 1437191376
$15,116.14
in general payments reported to CMS, 2019-2025
13 companies · $51.81 in 2025
The $51.81 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,570 · 2020: $5,225 · 2021: $4,047 · 2022: $38.06 · 2023: $169 · 2024: $14.70 · 2025: $51.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $14,165.71 | 2019-2021 | |
| Inari Medical, INC. | $350.07 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $146.62 | 2019 | |
| Corindus INC. | $112.61 | 2019 | |
| Penumbra, INC. | $85.00 | 2019 | |
| Boston Scientific Corporation | $84.11 | 2023 | Embold Fibered |
| Angiodynamics, INC. | $40.73 | 2022-2023 | Duraflow |
| Medtronic, INC. | $37.56 | 2021-2025 | Emprint |
| Ge Healthcare | $32.05 | 2021 | |
| Terumo Medical Corporation | $18.17 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.29 | 2025 | |
| Becton, Dickinson and Company | $14.70 | 2024 | Covera |
| Siemens Medical Solutions USA, INC. | $13.52 | 2025 | Mammomat B.Brilliant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Locke Barber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.